Literature DB >> 20237457

Coronary artery calcification and mortality in diabetic patients with proteinuria.

Yi-Wen Chiu1, Sharon G Adler, Matthew J Budoff, Junichiro Takasu, Jamila Ashai, Rajnish Mehrotra.   

Abstract

Vascular calcification is one of the mechanisms mediating the higher mortality risk associated with the hyperphosphatemia of chronic kidney disease. Though common, and often severe in non-dialyzed proteinuric diabetics, there are no studies on the prognostic significance of coronary artery calcification in early stage type 2 diabetic nephropathy. Here we determine this significance in 225 proteinuric diabetic patients (mean age 57 years, mean estimated glomerular filtration rate (eGFR) 52 ml/min per 1.73 m(2) and a median urine protein-creatinine ratio of 2.7). Coronary artery calcification, measured by electron beam computed tomography, was diagnosed in 86% of the patients, the severity of which correlated with older age, male gender, and white ethnicity. However, no association was found between eGFR, serum calcium, phosphorus, parathyroid hormone, or 25-hydroxy vitamin D. Over an average follow-up of 39 months, 54 patients died. A graded relationship between the severity of calcification and all-cause mortality was consistently demonstrated on both univariate and multivariate analyses. Patients in the highest quartile of calcification score had a 2.5-fold higher risk for death. Our results show the severity of coronary artery calcification early in the course of chronic kidney disease is an independent predictor of all-cause mortality. Additional studies need to determine whether altering the natural history of coronary artery calcification in early chronic kidney disease prolongs survival.

Entities:  

Mesh:

Year:  2010        PMID: 20237457     DOI: 10.1038/ki.2010.70

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  33 in total

1.  Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.

Authors:  Yusuke Izumi; Mutsuharu Hayashi; Ryota Morimoto; Xian Wu Cheng; Hongxian Wu; Hideki Ishii; Yoshinari Yasuda; Daiji Yoshikawa; Hideo Izawa; Seiichi Matsuo; Yutaka Oiso; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

Review 2.  Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2012-04-06

Review 3.  Non-invasive risk assessment in patients with chronic kidney disease.

Authors:  Abdul Hakeem; Sabha Bhatti; Alejandro R Trevino; Zainab Samad; Su Min Chang
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

4.  Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study.

Authors:  Amanda J Cox; Fang-Chi Hsu; Barry I Freedman; David M Herrington; Michael H Criqui; J Jeffrey Carr; Donald W Bowden
Journal:  Diabetes Care       Date:  2014-07-02       Impact factor: 19.112

5.  Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.

Authors:  Yupanqui A Caldas; Hector Giral; Michael A Cortázar; Eileen Sutherland; Kayo Okamura; Judith Blaine; Victor Sorribas; Hermann Koepsell; Moshe Levi
Journal:  Kidney Int       Date:  2011-06-15       Impact factor: 10.612

6.  Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease.

Authors:  Fellype C Barreto; Rodrigo B de Oliveira; Joyce Benchitrit; Loïc Louvet; Raja Rezg; Sabrina Poirot; Vanda Jorgetti; Tilman B Drüeke; Bruce L Riser; Ziad A Massy
Journal:  J Bone Miner Metab       Date:  2014-01-21       Impact factor: 2.626

Review 7.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

Review 8.  Coronary artery calcification in chronic kidney disease: An update.

Authors:  Tomasz Stompór
Journal:  World J Cardiol       Date:  2014-04-26

9.  Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.

Authors:  Brad P Dieter; Sterling M McPherson; Maryam Afkarian; Ian H de Boer; Rajnish Mehrotra; Robert Short; Celestina Barbosa-Leiker; Radica Z Alicic; Rick L Meek; Katherine R Tuttle
Journal:  J Diabetes Complications       Date:  2016-07-27       Impact factor: 2.852

10.  No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

Authors:  Rajnish Mehrotra; Carmen A Peralta; Shu-Cheng Chen; Suying Li; Michael Sachs; Anuja Shah; Keith Norris; Georges Saab; Adam Whaley-Connell; Bryan Kestenbaum; Peter A McCullough
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.